Among immunomodulatory factors released by AD-MSCs, IL1B, IL1RN, IL11, IL6, and IL15 showed elevated expression, while IL16 and TGFB3 showed decreased expression in a TNFα environment. This evidence concerns the gene TGFB3 and Alzheimer disease.